2 Pot Stocks to Buy Before Canada’s Cannabis 2.0 Legalization

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and Hexo Corp (TSX:HEXO)(NYSE:HEXO) are headed for a collision course in the Cannabis 2.0 market. Now is the time to take sides.

| More on:

Canada will legalize cannabis-infused edibles for recreational use this month. The selection of products that will be available in retail outlets, however, will be limited. Nonetheless, the cannabis edibles, extracts, and topical market is estimated to be worth $2.7 billion annually.

Canopy Growth (TSX:WEED)(NYSE:CGC) and Hexo (TSX:HEXO)(NYSE:HEXO) are the pot stocks competing for market leadership in this growth opportunity and have delivered the significant gains to investors.

Potential champion

Canopy continues to disappoint investors so far, and the huge losses recently are worrisome. However, among all cannabis producers, this company has spent the most time and resources toward Cannabis 2.0. Its efforts will soon pay off.

The partnership with alcoholic beverage maker Constellation Brands is a clear sign that Canopy is likely to assume the leadership position in the cannabis-infused beverages market segment. Expect Canopy Growth to introduce multiple cannabis beverages, including zero and low-calorie drinks.

Mark Zekulin, Canopy’s interim CEO, believes that the cannabis beverages market will expand the cannabis consumer category to reach a larger portion of the population. Aside from beverages, Canopy will sell a variety of CBD products, including edibles and oils, later this fiscal year.

Since early July, Canopy has fallen sharply by 41%. But I expect the stock to gain strong momentum when the legal production and sales of cannabis beverages and edibles go into full swing. WEED could rise to $85 or a potential gain of 169%.

Worthy contender

Canopy isn’t the only cannabis producer with a solid financial backer. HEXO is likewise in the best position to be a big winner in the Cannabis 2.0 market. The main objective of forming Truss, a joint venture with beer maker Molson Coors Brewing, is to develop and market cannabis-infused beverages.

That market segment is Hexo’s primary focus. Last June, Hexo CEO Sebastien St.-Louis said that he hasn’t “seen anything else in the industry right now that compares to what we have today” with the first version of its cannabis-infused beverage.

But the company made it known that brisk sales won’t come from cannabis-infused beverages only. HEXO is also developing gummies and premium vape products. St.-Louis believes that these two could be the top-selling products that could match beverages in terms of market opportunity.

The competitive advantage of Hexo is its dominance in the province of Quebec. Currently, HEXO holds a leading market share of 30% in the province that ranks second to Ontario in terms of population size.

Hexo is down 19.0% since early June, but because of its enormous growth potential in the Cannabis 2.0 market, analysts are forecasting a 152% potential upside in the next 12 months.

Collision course

Expect a few kinks before the beverages and edibles markets get going. Health Canada is the process of crafting a strict legal framework that would ensure public safety. The cannabis sector is on the verge of creating valuable new growth opportunities with cannabis edibles and other alternative products.

But the winner in the Cannabis 2.0 market is a toss-up between team Canopy-Constellation and team Hexo-Molson Coors. It’s is going to be an exciting head-to-head battle. Pick your pot stock now, and may the better side win.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »